216 Participants Needed

Training for Urinary Incontinence After Pregnancy

(TULIP Trial)

Recruiting at 6 trial locations
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: NICHD Pelvic Floor Disorders Network
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This is a multi-center, randomized single-blind nonsurgical trial conducted in approximately 216 primiparous postpartum women at high risk for prolonged/sustained pelvic floor disorders with symptomatic, bothersome urinary incontinence (UI) amenable to nonsurgical treatment. TULIP is a 3-Arm trial with two active interventions (Arms 1 and 2) and a Patient Education control arm (Arm 3). Arm 1 consists of pelvic floor muscle training (PFMT). Arm 2 uses a home biofeedback device (leva®). The primary outcome will be assessed at 6 months postpartum by blinded outcomes assessors, and follow-up will continue until 12 months postpartum.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.

What data supports the effectiveness of this treatment for urinary incontinence after pregnancy?

Research shows that pelvic floor muscle training (PFMT) combined with biofeedback devices can help improve stress urinary incontinence. A study found that using a home biofeedback device for PFMT was more effective than PFMT alone in managing stress urinary incontinence in women.12345

Is the leva device safe for use in humans?

The research does not provide specific safety data for the leva device, but pelvic floor muscle training (PFMT) with biofeedback devices is commonly used and generally considered safe for stress urinary incontinence.15678

How is the leva device treatment for urinary incontinence after pregnancy different from other treatments?

The leva device treatment is unique because it combines home pelvic floor exercises with a biofeedback device that guides users, making it easier to perform the exercises correctly and consistently. This approach helps overcome the common issue of low motivation in patients to continue pelvic floor muscle training on their own.156910

Research Team

DR

David Rahn, MD

Principal Investigator

UTSW

MG

Marie Gantz, PhD

Principal Investigator

RTI International

Eligibility Criteria

This trial is for new mothers who have just had their first child and are experiencing urinary incontinence. Participants should be at high risk for long-term pelvic floor disorders but able to undergo nonsurgical treatments.

Inclusion Criteria

I am over 18, recently had my first child by vaginal delivery after 32 weeks, and it's been about 6 weeks.
I am at high risk for pelvic floor disorders after childbirth.

Exclusion Criteria

Stillbirth or significant maternal or neonatal illness
Unwilling or unable to upload and use external smartphone app(s)
I cannot follow instructions for pelvic floor muscle training at home or in-person.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either interventionist-guided pelvic floor muscle training, home biofeedback device training, or education on pelvic floor muscle function

6 months
2 visits (in-person) for interventionist-guided training, ongoing home exercises

Follow-up

Participants are monitored for changes in urinary incontinence and other secondary outcomes

6 months
Monthly questionnaires sent to participants

Extension

Continued monitoring and assessment of adherence to interventions and secondary outcomes

6 months

Treatment Details

Interventions

  • Home pelvic floor exercises guided by the leva® device
  • Interventionist-guided training
Trial OverviewThe study compares two active interventions against a control group receiving only education. One group will do pelvic floor muscle training, another will use the leva® biofeedback device at home, and the third gets educational materials.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: EducationExperimental Treatment1 Intervention
Education will be provided on pelvic floor muscle function and continence mechanisms. No specific prescription or verbal direction will be given regarding the suggested number and frequency of home pelvic floor muscle exercises.
Group II: Interventionist-guided trainingActive Control1 Intervention
Interventionist-guided training at baseline, followed by a Home Exercise Prescription (HEP), a second interventionist-guided training session, and then continued HEP. Home exercises will be encouraged/ augmented using a PFDN research smartphone app.
Group III: Home pelvic floor exercises guided by the leva® deviceActive Control1 Intervention
Home pelvic floor exercises guided by the leva® device and its accompanying app/software for gradually increasing strength and duration of pelvic floor contractions. The PFDN research smartphone app will have weekly queries of whether exercises were completed.

Home pelvic floor exercises guided by the leva® device is already approved in United States for the following indications:

🇺🇸
Approved in United States as leva device for:
  • Stress urinary incontinence
  • Urinary incontinence postpartum

Find a Clinic Near You

Who Is Running the Clinical Trial?

NICHD Pelvic Floor Disorders Network

Lead Sponsor

Trials
16
Recruited
4,900+

RTI International

Collaborator

Trials
201
Recruited
942,000+

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator

Trials
2,103
Recruited
2,760,000+

University of Chicago

Collaborator

Trials
1,086
Recruited
844,000+

University of Pennsylvania

Collaborator

Trials
2,118
Recruited
45,270,000+

Duke University

Collaborator

Trials
2,495
Recruited
5,912,000+

Kaiser Permanente

Collaborator

Trials
563
Recruited
27,400,000+

University of California, San Diego

Collaborator

Trials
1,215
Recruited
1,593,000+

University of Texas Southwestern Medical Center

Collaborator

Trials
1,102
Recruited
1,077,000+

Women and Infants Hospital of Rhode Island

Collaborator

Trials
119
Recruited
59,200+

Findings from Research

The study involved 66 women, including 31 with genuine stress incontinence and 35 healthy controls, using an EMG-based device to measure pelvic floor muscle activity during contractions, revealing that incontinent patients had significantly lower muscle activity in the standing position compared to controls.
The findings suggest that pelvic floor muscle activity decreases with age, and while the EMG device may not yet be a fully established diagnostic tool, it shows promise in guiding pelvic floor muscle training for patients with incontinence.
The effect of aging on the electromyographic activity of pelvic floor muscles. A comparative study among stress incontinent patients and asymptomatic women.Aukee, P., Penttinen, J., Airaksinen, O.[2019]
In a study of 35 women with urodynamic stress urinary incontinence, those using pelvic floor training (PFT) with a home biofeedback device had a success rate of 68.8% in avoiding surgery after one year, compared to 52.6% in the PFT alone group, although this difference was not statistically significant.
Significant improvements in pelvic floor muscle activity and a decrease in leakage index were observed in the home biofeedback group after 12 weeks, indicating that this method may enhance the effectiveness of pelvic floor training for managing urinary incontinence.
The effect of home biofeedback training on stress incontinence.Aukee, P., Immonen, P., Laaksonen, DE., et al.[2004]
A 24-week pelvic floor muscle training program significantly improved urinary incontinence symptoms in 66 participants with prostate cancer, as evidenced by reductions in symptom intensity, frequency, and activity limitations (p≤.0001).
Participants in the experimental group also experienced a notable improvement in waist perimeter (p≤.001) and quality of life, indicating that better management of urinary incontinence can enhance overall well-being (p=.039).
Urinary incontinence and prostate cancer: a progressive rehabilitation program design.Serdà, BC., Marcos-Gragera, R.[2014]

References

The effect of aging on the electromyographic activity of pelvic floor muscles. A comparative study among stress incontinent patients and asymptomatic women. [2019]
The effect of home biofeedback training on stress incontinence. [2004]
Urinary incontinence and prostate cancer: a progressive rehabilitation program design. [2014]
Effect of Pelvic Floor Muscle Training With Smartphone Reminders on Women in the Postpartum Period: A Randomized Controlled Trial. [2023]
Device to promote pelvic floor muscle training for stress incontinence. [2019]
Implementing pelvic floor muscle training in women's childbearing years: A critical interpretive synthesis of individual, professional, and service issues. [2021]
Pelvic floor muscle training for stress urinary incontinence: a randomized, controlled trial comparing different conservative therapies. [2014]
Self-management of incontinence using a free mobile app: factors associated with improvement. [2022]
Pelvic floor muscle training for prevention and treatment of urinary and fecal incontinence in antenatal and postnatal women: a short version Cochrane review. [2018]
KEPT-app trial: a pragmatic, single-blind, parallel, cluster-randomised effectiveness study of pelvic floor muscle training among incontinent pregnant women: study protocol. [2021]